These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 8993250)
61. Heparin-coated bypass circuits in cardiopulmonary bypass: improved biocompatibility or not. Levy M; Hartman AR Int J Cardiol; 1996 Apr; 53 Suppl():S81-7. PubMed ID: 8793597 [TBL] [Abstract][Full Text] [Related]
62. Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery. Bozdayi M; Borowiec J; Nilsson L; Venge P; Thelin S; Hansson HE Artif Organs; 1996 Sep; 20(9):1008-16. PubMed ID: 8864022 [TBL] [Abstract][Full Text] [Related]
64. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis. Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142 [TBL] [Abstract][Full Text] [Related]
65. Quantitative evaluation of heparin-coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass. Stammers AH; Christensen KA; Lynch J; Zavadil DP; Deptula JJ; Sydzyik RT J Extra Corpor Technol; 1999 Sep; 31(3):135-41. PubMed ID: 10847956 [TBL] [Abstract][Full Text] [Related]
66. [The evaluation of the bio-compatibility and the clinical usefulness of heparin-coated cardiopulmonary bypass circuits]. Yamanaka J; Takeuchi Y; Torii S; Gomi A; Nakatani H; Kohno K Nihon Kyobu Geka Gakkai Zasshi; 1996 Jan; 44(1):47-53. PubMed ID: 8683171 [TBL] [Abstract][Full Text] [Related]
67. Heparin coating with aprotinin reduces blood activation during coronary artery operations. Baufreton C; Jansen PG; Le Besnerais P; te Velthuis H; Thijs CM; Wildevuur CR; Loisance DY Ann Thorac Surg; 1997 Jan; 63(1):50-6. PubMed ID: 8993240 [TBL] [Abstract][Full Text] [Related]
68. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization. Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380 [TBL] [Abstract][Full Text] [Related]
69. Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro. Høgevold HE; Moen O; Fosse E; Venge P; Bråten J; Andersson C; Lyberg T Perfusion; 1997 Mar; 12(1):9-20. PubMed ID: 9131716 [TBL] [Abstract][Full Text] [Related]
70. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation. Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960 [TBL] [Abstract][Full Text] [Related]
71. Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. Baufreton C; Intrator L; Jansen PG; te Velthuis H; Le Besnerais P; Vonk A; Farcet JP; Wildevuur CR; Loisance DY Ann Thorac Surg; 1999 Apr; 67(4):972-7. PubMed ID: 10320237 [TBL] [Abstract][Full Text] [Related]
72. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits). Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550 [TBL] [Abstract][Full Text] [Related]
73. Differential expression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass. Ilton MK; Langton PE; Taylor ML; Misso NL; Newman M; Thompson PJ; Hung J J Thorac Cardiovasc Surg; 1999 Nov; 118(5):930-7. PubMed ID: 10534700 [TBL] [Abstract][Full Text] [Related]
74. Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery. Belboul A; al-Khaja N Perfusion; 1997 Nov; 12(6):385-91. PubMed ID: 9413851 [TBL] [Abstract][Full Text] [Related]
75. Active or passive bio-coating: does it matters in extracorporeal circulation? Jacobs S; De Somer F; Vandenplas G; Van Belleghem Y; Taeymans Y; Van Nooten G Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530 [TBL] [Abstract][Full Text] [Related]
76. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Nilsson L; Storm KE; Thelin S; Bagge L; Hultman J; Thorelius J; Nilsson U Artif Organs; 1990 Feb; 14(1):46-8. PubMed ID: 2302076 [TBL] [Abstract][Full Text] [Related]
78. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. Borowiec J; Thelin S; Bagge L; Nilsson L; Venge P; Hansson HE J Thorac Cardiovasc Surg; 1992 Sep; 104(3):642-7. PubMed ID: 1325013 [TBL] [Abstract][Full Text] [Related]
79. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass. de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987 [TBL] [Abstract][Full Text] [Related]